5 Best Medical Stocks Under $20

Page 1 of 5

In this article, we discuss 5 best medical stocks under $20. If you want to see more stocks in this selection, check out 10 Best Medical Stocks Under $20

5. AbCellera Biologics Inc. (NASDAQ:ABCL)

Number of Hedge Fund Holders: 26

Share Price as of December 8: $11.08

AbCellera Biologics Inc. (NASDAQ:ABCL) is headquartered in Vancouver, Canada, and the company develops a full-stack, artificial intelligence-powered antibody discovery platform that searches and analyzes the database of natural immune systems to discover antibodies that could be developed as drugs. AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best medical stocks to invest in. 

On November 16, Truist analyst Robyn Karnauskas initiated coverage of AbCellera Biologics Inc. (NASDAQ:ABCL) with a Buy rating and a $29 price target. The company is a pioneer in tech-enabled biotech with a proprietary platform that drives swift discovery of antibodies and is validated by the approval of two COVID drugs and 5 molecules in the clinic, the analyst told investors. She added that AbCellera Biologics Inc. (NASDAQ:ABCL) is undervalued, with potential for upside over next 12-24 months coming from new partnerships with better economics and further validation of its platform as programs advance to the clinical stage.

According to Insider Monkey’s data, 26 hedge funds were bullish on AbCellera Biologics Inc. (NASDAQ:ABCL) at the end of September 2022, compared to 17 funds in the prior quarter. Julian Baker and Felix Baker’s Baker Bros. Advisors is the largest stakeholder of the company, with 10.45 million shares worth $103.35 million. 

Follow Abcellera Biologics Inc. (NASDAQ:ABCL)

Page 1 of 5